TRUSTS: A Phase IIB/III Multicenter Study Comparing the Efficacy of TRabectedin Administered as a 3-Hour or 24-Hour Infusion to Doxorubicin in Patients With Advanced or Metastatic Untreated Soft Tissue Sarcoma.
Phase of Trial: Phase II/III
Latest Information Update: 10 Nov 2016
At a glance
- Drugs Trabectedin (Primary) ; Doxorubicin
- Indications Soft tissue sarcoma
- Focus Adverse reactions; Therapeutic Use
- Acronyms TRUSTS
- 09 Nov 2016 This trial has been completed in Poland (End date:2016-04-16) as per European Clinical Trials Database record.
- 24 Jun 2016 The trial was completed in Denmark.
- 21 Jun 2016 The trial was completed in Germany (end date:2016-04-16).